ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,938.84
-0.21%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Hi-Tech Pharmacal Co., Inc. (MM) (HITK)

  7. Hi-Tech Pharmacal Co., Inc. (MM) (HITK) Noticias

HITK

Hi Tech (HITK)

Hi-Tech Pharmacal Co., Inc. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:HITK
FechaHoraFuenteTítuloSímboloCompañía
08/04/201513:27Business WireKeller Rohrback L.L.P. Announces Investigation Regarding Weight-Loss & Workout Supplements Containing Potentially Dangerous A...NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
28/04/201412:39Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
21/04/201411:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
17/04/201412:13Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
17/04/201409:27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
17/04/201408:20Business WireAkorn Completes Acquisition of Hi-Tech PharmacalNASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
17/04/201408:06Edgar (US Regulatory)(25-NSE)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
15/04/201416:53PR Newswire (US)Repligen Corporation Set to Join the S&P SmallCap 600NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
14/04/201418:00Business WireAkorn Receives FTC Clearance for Hi-Tech Pharmacal AcquisitionNASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
13/03/201415:22Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
11/03/201410:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
11/03/201406:00Business WireHi-Tech Pharmacal Reports Sales of $59.9 Million for the Third Quarter Ended January 31, 2014NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
10/03/201409:59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
12/02/201405:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
23/01/201406:00Business WireHi-Tech Pharmacal Receives Final Approval for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
26/12/201306:00Business WireHi-Tech Pharmacal Announces Settlement Regarding Texas Pricing InvestigationNASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
10/12/201306:00Business WireHi-Tech Pharmacal Reports Sales of $58.6 million for the Second Quarter Ended October 31, 2013NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
15/11/201306:11Dow Jones NewsAQR Capital Management 3Q 13F: Largest Purchases -2-NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
15/11/201306:11Dow Jones NewsAQR Capital Management 3Q 13F: Largest PurchasesNASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
15/11/201306:11Dow Jones NewsAQR Capital Management 3Q 13F: Holdings As Of Sep -2-NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
15/11/201306:11Dow Jones NewsAQR Capital Management 3Q 13F: Holdings As Of Sep 30NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
14/11/201306:21Dow Jones NewsGAMCO Asset Management Inc. 3Q 13F: Largest -2-NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
14/11/201306:21Dow Jones NewsGAMCO Asset Management Inc. 3Q 13F: Largest PurchasesNASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
07/11/201316:30Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
10/10/201316:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
25/09/201315:11PR Newswire (US)Acquisition of Hi-Tech Pharmacal Co., Inc. (HITK) by Akorn, Inc. (AKRX) May Be Detrimental to the Interests of Hi-Tech Pharma...NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
24/09/201316:22Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
13/09/201314:00Business WireHI-TECH PHARMACAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Launches an Investigation of Hi-Tech Pharmacal Co., Inc. (HITK) Ov...NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
11/09/201313:35Business WireSHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Hi-Tech Pharmacal Co.NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
09/09/201315:47MarketwiredHI-TECH PHARMACAL CO. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by ...NASDAQ:HITKHi-Tech Pharmacal Co., Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:HITK

Su Consulta Reciente

ASX
MPE
COIN
GMEEEUSD
GAMEE
XE
SB1
Smartbroker
COIN
MICROUSD
MICROMINES
EU
CAFME
CAC 40 Futures Monthly R...
LSE
78LQ
Anz Bank 24
ASX
LLCKOR
BIT
UB8C61
Unicredit Bank
ASX
TTSKOD
EU
IFCSG
FT FCSG INAV
ASX
OLI
Olivers Real Food
COIN
PZSGBP
PAYZUS
OKEX
PAXUSDT
NASDAQ
AAXRRXX
HSBC USA Inc. Issuer Cal...
NASDAQ
AAZBTXX
Hsbc Usa Inc Autocallabl...
ASX
SPFKOP
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados